Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?

For identification (ID) of irregular antibodies, a standard antibody identification (AI) panel consisting of 18 mandatory antigens expressed on reagent red blood cells is used. The phenotype for each antigen is listed on a red cell antigram provided with each lot of the ID panel. In addition, specia...

Full description

Saved in:
Bibliographic Details
Main Authors: Rasika Dhawan Setia, Gunjan Bhardwaj, Mitu Dogra, Amena Ebadur Rahman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-11-01
Series:Global Journal of Transfusion Medicine
Subjects:
Online Access:https://journals.lww.com/10.4103/gjtm.gjtm_85_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846139442374377472
author Rasika Dhawan Setia
Gunjan Bhardwaj
Mitu Dogra
Amena Ebadur Rahman
author_facet Rasika Dhawan Setia
Gunjan Bhardwaj
Mitu Dogra
Amena Ebadur Rahman
author_sort Rasika Dhawan Setia
collection DOAJ
description For identification (ID) of irregular antibodies, a standard antibody identification (AI) panel consisting of 18 mandatory antigens expressed on reagent red blood cells is used. The phenotype for each antigen is listed on a red cell antigram provided with each lot of the ID panel. In addition, special type of low-incidence antigens that are clinically significant are separately mentioned on the left- or right-hand column or on the reverse of the antigram. These cases highlight the importance of diligent AI to ensure safe transfusions and prevent adverse transfusion reactions in patients. The ID of rare and low-incidence red cell alloantibodies is important in ensuring safe transfusions and preventing hemolytic disease of fetus and newborn. In routine practice, these types of antibodies are often categorized as having an undetermined specificity due to their rarity and low prevalence in the population. We describe two cases of successful ID of rare and low-incidence red cell alloantibodies, Anti-Colton-b (Co(b)) and Anti-Kpa. Type and screen and irregular AI were performed on Immucor NEO Iris® (SPRCA), for both the female patients. Autocontrol and direct agglutination test were performed by column agglutination technique method (BIO-RAD, Coombs Anti-Ig G cards) and were negative for both the patients. Analysis of respective antigrams was done to rule out or rule in irregular antibodies. Initially, the reaction pattern indicated the presence of anti-Co(b) and anti-Kpa. However, the reaction only occurred in one cell out of the 14 cells tested for both patients. To ensure accuracy, the samples were rerun using different lots using the SPRCA methodology. To confirm the presence of anti-Co(b) antibodies, a selected panel cell was treated with an enzyme to enhance the expression of the Co(b+) antigen. Anti-Co(b) and anti-Kpa alloantibodies were successfully identified and AHG crossmatched; compatible and phenotype-matched blood units were reserved for the patients. Low prevalence antibodies are often missed during antibody screening due to lack of corresponding antigen-positive cells in cell panels or due to their weak reaction pattern and considering it for nonspecific reaction.
format Article
id doaj-art-d5c3d57d77044d03991b58c7b9f6071e
institution Kabale University
issn 2468-8398
2455-8893
language English
publishDate 2024-11-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Global Journal of Transfusion Medicine
spelling doaj-art-d5c3d57d77044d03991b58c7b9f6071e2024-12-06T10:12:50ZengWolters Kluwer Medknow PublicationsGlobal Journal of Transfusion Medicine2468-83982455-88932024-11-019213413810.4103/gjtm.gjtm_85_23Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?Rasika Dhawan SetiaGunjan BhardwajMitu DograAmena Ebadur RahmanFor identification (ID) of irregular antibodies, a standard antibody identification (AI) panel consisting of 18 mandatory antigens expressed on reagent red blood cells is used. The phenotype for each antigen is listed on a red cell antigram provided with each lot of the ID panel. In addition, special type of low-incidence antigens that are clinically significant are separately mentioned on the left- or right-hand column or on the reverse of the antigram. These cases highlight the importance of diligent AI to ensure safe transfusions and prevent adverse transfusion reactions in patients. The ID of rare and low-incidence red cell alloantibodies is important in ensuring safe transfusions and preventing hemolytic disease of fetus and newborn. In routine practice, these types of antibodies are often categorized as having an undetermined specificity due to their rarity and low prevalence in the population. We describe two cases of successful ID of rare and low-incidence red cell alloantibodies, Anti-Colton-b (Co(b)) and Anti-Kpa. Type and screen and irregular AI were performed on Immucor NEO Iris® (SPRCA), for both the female patients. Autocontrol and direct agglutination test were performed by column agglutination technique method (BIO-RAD, Coombs Anti-Ig G cards) and were negative for both the patients. Analysis of respective antigrams was done to rule out or rule in irregular antibodies. Initially, the reaction pattern indicated the presence of anti-Co(b) and anti-Kpa. However, the reaction only occurred in one cell out of the 14 cells tested for both patients. To ensure accuracy, the samples were rerun using different lots using the SPRCA methodology. To confirm the presence of anti-Co(b) antibodies, a selected panel cell was treated with an enzyme to enhance the expression of the Co(b+) antigen. Anti-Co(b) and anti-Kpa alloantibodies were successfully identified and AHG crossmatched; compatible and phenotype-matched blood units were reserved for the patients. Low prevalence antibodies are often missed during antibody screening due to lack of corresponding antigen-positive cells in cell panels or due to their weak reaction pattern and considering it for nonspecific reaction.https://journals.lww.com/10.4103/gjtm.gjtm_85_23alloantibodiesantibody identificationlow-incidence antigensred cell antigramselect cells
spellingShingle Rasika Dhawan Setia
Gunjan Bhardwaj
Mitu Dogra
Amena Ebadur Rahman
Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
Global Journal of Transfusion Medicine
alloantibodies
antibody identification
low-incidence antigens
red cell antigram
select cells
title Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
title_full Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
title_fullStr Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
title_full_unstemmed Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
title_short Antibody of Undetermined Specificity - The Eyes Do Not See What the Mind Does Not Know: Are You Dealing with a Low Prevalence Red Blood Cell Antigens?
title_sort antibody of undetermined specificity the eyes do not see what the mind does not know are you dealing with a low prevalence red blood cell antigens
topic alloantibodies
antibody identification
low-incidence antigens
red cell antigram
select cells
url https://journals.lww.com/10.4103/gjtm.gjtm_85_23
work_keys_str_mv AT rasikadhawansetia antibodyofundeterminedspecificitytheeyesdonotseewhattheminddoesnotknowareyoudealingwithalowprevalenceredbloodcellantigens
AT gunjanbhardwaj antibodyofundeterminedspecificitytheeyesdonotseewhattheminddoesnotknowareyoudealingwithalowprevalenceredbloodcellantigens
AT mitudogra antibodyofundeterminedspecificitytheeyesdonotseewhattheminddoesnotknowareyoudealingwithalowprevalenceredbloodcellantigens
AT amenaebadurrahman antibodyofundeterminedspecificitytheeyesdonotseewhattheminddoesnotknowareyoudealingwithalowprevalenceredbloodcellantigens